Search
Psyence Biomedical Ltd
PBMAdd to Watchlist
3.040USD
-0.070-2.25%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
34.67KMarket Cap
LossP/E TTM
More Details of Psyence Biomedical Ltd Company
Psyence Biomedical Ltd is a multi-asset, vertically integrated biopharmaceutical company specializing in psychedelic-based therapeutics. The Company is focused on developing nature-derived (non-synthetic) psilocybin-based psychedelic medicine. It is dedicated to addressing unmet mental health needs, particularly in palliative care. Its ongoing Phase IIb psilocybin clinical trial in Australia focuses on adjustment disorder in patients diagnosed with cancer.
Psyence Biomedical Ltd Info
Ticker SymbolPBM
Company namePsyence Biomedical Ltd
IPO dateDec 10, 2021
CEOMaresky (Neil)
Number of employees12
Security typeOrdinary Share
Fiscal year-endDec 10
Address121 Richmond Street West Penthouse
CityTORONTO
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryCanada
Postal codeM5H 2K1
Phone17744604171
Website
Ticker SymbolPBM
IPO dateDec 10, 2021
CEOMaresky (Neil)
Company Executives of Psyence Biomedical Ltd
Name
Name/Position
Position
Shareholding
Change
Dr. Neil Maresky
Dr. Neil Maresky
Chief Executive Officer, Director
Chief Executive Officer, Director
1.56K
--
Dr. Jody Aufrichtig
Dr. Jody Aufrichtig
Chairman of the Board, Strategic Business Development Officer
Chairman of the Board, Strategic Business Development Officer
885.00
--
Mr. Warwick Corden-Lloyd
Mr. Warwick Corden-Lloyd
Chief Financial Officer
Chief Financial Officer
491.00
--
Mr. Marc Balkin
Mr. Marc Balkin
Independent Director
Independent Director
--
--
Mr. Christopher (Chris) Bull
Mr. Christopher (Chris) Bull
Independent Director
Independent Director
--
--
Dr. Seth Feuerstein
Dr. Seth Feuerstein
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Shareholding
Change
Dr. Neil Maresky
Dr. Neil Maresky
Chief Executive Officer, Director
Chief Executive Officer, Director
1.56K
--
Dr. Jody Aufrichtig
Dr. Jody Aufrichtig
Chairman of the Board, Strategic Business Development Officer
Chairman of the Board, Strategic Business Development Officer
885.00
--
Mr. Warwick Corden-Lloyd
Mr. Warwick Corden-Lloyd
Chief Financial Officer
Chief Financial Officer
491.00
--
Mr. Marc Balkin
Mr. Marc Balkin
Independent Director
Independent Director
--
--
Mr. Christopher (Chris) Bull
Mr. Christopher (Chris) Bull
Independent Director
Independent Director
--
--
Dr. Seth Feuerstein
Dr. Seth Feuerstein
Independent Director
Independent Director
--
--
FAQs
Who are the top five shareholders of Psyence Biomedical Ltd?
The top five shareholders of Psyence Biomedical Ltd are: Dr. Neil Maresky
How many institutions hold shares of Psyence Biomedical Ltd (PBM)?
As of 2026Q1, 24 institutions hold shares of Psyence Biomedical Ltd, with a combined market value of approximately 159.81K, accounting for 6.96% of the total shares. Compared to 2025Q4, institutional shareholding has increased by 112677.00.